BLCO - חוב כולל להון Bausch Health

This daily price chart of the total debt-to-equity ratio for Bausch + Lomb Corporation (BLCO), which specializes in ophthalmology solutions, captures the metric at 0.80. Borrowing stability is supported by the low elasticity of demand for optics, which allows the company to pass inflation onto consumers. Management is focusing on upgrading production capacities for expansion, seeking global dominance through the launch of innovative treatments for cataracts and dry eye.

High leverage at Bausch + Lomb Corporation (BLCO) following restructuring and competitive pressure are constraining its free cash flow. By analyzing the total debt-to-equity ratio, an investor assesses the proportion of borrowed funds to equity assets, where a decrease in the metric signals growing financial stability, while an increase indicates heightened risks when scaling the business.